• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多基因panel 检测在乳腺癌中的应用。

Application Of Multigene Panel Detection In Breast Cancer.

机构信息

Department of Oncology,PuerPeople's Hospital,China.

Department of Oncology,Puer People's Hospital,China.

出版信息

J Pak Med Assoc. 2023 Sep;73(9):1862-1868. doi: 10.47391/JPMA.6830.

DOI:10.47391/JPMA.6830
PMID:37817699
Abstract

Precision medicine will be the direction of future medical development, especially in cancer diagnosis and treatment. With the deepening of breast cancer-related research, new factors related to diagnosis, treatment and prognosis are constantly being discovered. Researchers combine different factorsto form a multigene panel testing, guiding clinicians' decision-making. The application scope of multigene panel detection is constantly expanding. At present, it has been tried in the prognosis evaluation of lymph node-positive and human epidermal growth factor receptor 2-positive breast cancer patients and the early screening of breast cancer. With continuous technological advancement, there will be broader application prospects in the future. The current narrative review was planned to evaluate the recent advances in applying multigene panel testing in breast cancer cases.

摘要

精准医学将是未来医学发展的方向,尤其在癌症的诊断和治疗方面。随着乳腺癌相关研究的深入,新的与诊断、治疗和预后相关的因素不断被发现。研究者们将不同的因素结合起来形成多基因panel 检测,指导临床医生进行决策。多基因 panel 检测的应用范围不断扩大,目前已经尝试应用于淋巴结阳性和人表皮生长因子受体 2 阳性乳腺癌患者的预后评估和乳腺癌的早期筛查中。随着技术的不断进步,未来将会有更广阔的应用前景。本综述旨在评估多基因 panel 检测在乳腺癌中的应用进展。

相似文献

1
Application Of Multigene Panel Detection In Breast Cancer.多基因panel 检测在乳腺癌中的应用。
J Pak Med Assoc. 2023 Sep;73(9):1862-1868. doi: 10.47391/JPMA.6830.
2
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.肿瘤分析测试指导早期乳腺癌辅助化疗决策:系统评价和经济分析。
Health Technol Assess. 2019 Jun;23(30):1-328. doi: 10.3310/hta23300.
3
Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline.多基因谱分析检测在早期浸润性乳腺癌中的临床效用:安大略省卫生厅(安大略省癌症护理)临床实践指南。
Curr Oncol. 2022 Apr 9;29(4):2599-2615. doi: 10.3390/curroncol29040213.
4
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.基因表达谱分析和扩展免疫组织化学检测在乳腺癌管理中指导辅助化疗的应用:系统评价和成本效益分析。
Health Technol Assess. 2013 Oct;17(44):1-302. doi: 10.3310/hta17440.
5
The multigene classifiers 95GC/42GC/155GC for precision medicine in ER-positive HER2-negative early breast cancer.用于 ER 阳性 HER2 阴性早期乳腺癌精准医学的多基因分类器 95GC/42GC/155GC。
Cancer Sci. 2021 Apr;112(4):1369-1375. doi: 10.1111/cas.14838. Epub 2021 Feb 26.
6
Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.用于指导早期乳腺癌女性辅助化疗决策的基因表达谱分析:基于证据的经济分析
Ont Health Technol Assess Ser. 2010;10(23):1-57. Epub 2010 Dec 1.
7
Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?EGAPP工作组的建议:使用Oncotype DX肿瘤基因表达谱来指导治疗决策是否能改善乳腺癌患者的预后?
Genet Med. 2016 Aug;18(8):770-9. doi: 10.1038/gim.2015.173. Epub 2015 Dec 17.
8
[A Review Multigene Assays for Clinical Utility in Breast Cancer].[乳腺癌临床应用多基因检测综述]
Gan To Kagaku Ryoho. 2016 Nov;43(11):1332-1340.
9
Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making.多基因标志物面板与乳腺癌治疗:使用模式与对临床决策的影响。
J Am Coll Surg. 2018 Apr;226(4):406-412.e1. doi: 10.1016/j.jamcollsurg.2017.12.043. Epub 2018 Jan 31.
10
A narrative review of five multigenetic assays in breast cancer.一篇关于乳腺癌中五种多基因检测方法的叙述性综述。
Transl Cancer Res. 2022 Apr;11(4):897-907. doi: 10.21037/tcr-21-1920.

引用本文的文献

1
Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status.考虑种系 BRCA1/2 突变状态的乳腺癌组织中同源重组修复(HRR)基因表达的改变。
Breast Cancer Res Treat. 2024 Dec;208(3):501-510. doi: 10.1007/s10549-024-07441-4. Epub 2024 Jul 30.